People

Samuel Waksal

Founder and chief executive officer of Graviton Bioscience, a developer of ROCK2 inhibitors for neurological, immune and fibrotic disorders. Previously founded and led ImClone Systems and Kadmon, and founded MeiraGTx; his background includes academic biomedical research.